GSK Consumer Helathcare - First Cut - Microsec

GSK Consumer Healthcare announced its Q2 CY13 results on 01 Aug 2013. The company's Net Sales increased by 17% YOY to 890 crore and its EBITDA increased by 12% YOY to INR156 crore. EBITDA Margin of the company decreased from 18.4% to 17.5% YOY. PAT of the company increased by 13% YOY to INR120 crore. We have recommended the stock at the level of INR2977 with a target price of INR3642 which had been achieved. At the CMP of INR4580, the stock discounts its CY13E of INR127.3 by 35.6x . We remain Neutral to the stock.

Source : Equity Bulls

Keywords